Workforce Digital Transformation Summit 2023

Last updated Dec 14, 2022 0

Covid19 disruption, changes in business priorities and endless technological innovations have created the new working paradigm which expands beyond location, time and convenient work models.

The Role of the Senior HR Manager Training Course

HR Leadership Summit

Leave A Reply

Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering

2026-06-23T08:00:00Z

JUPITER, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today the pricing of $625.0 million aggregate principal amount of 0.0% convertible senior notes due...

Transactions in connection with share buy-back program

2026-06-23T08:00:00Z

Company announcement no. 22 - 2623 June 2026

CGA.vitaslim Announces Mission to Help 5,000 Adults Combat the "Three Highs" and Reclaim Their Health and Wealth in Hong Kong

2026-06-23T06:54:00Z

HONG KONG, June 23, 2026 (GLOBE NEWSWIRE) -- CGA.vitaslim, a premier health and wellness consultancy, today announced the launch of a new community-focused initiative aimed at helping 5,000 individuals aged...

Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission

2026-06-23T06:30:00Z

ORION CORPORATION PRESS RELEASE 23 JUNE 2026 at 9:30 EEST Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission

BienRaíz Launches Vitamin D3 5000 IU Softgels: A High-Potency, Simple Formula for Everyday Wellness

2026-06-23T05:44:31Z

New Vitamin D3 Supplement Delivers 5000 IU of Cholecalciferol in Easy-to-Take Softgels Designed for Adults Seeking a Flexible Daily Wellness Routine

Nicox and Vester Finance Sign Shareholder Loan Agreement to Support Strategic Activities for the Company

2026-06-23T05:30:00Z

1 Lower of the two daily volume-weighted average prices over the period immediately preceding each issue.2 At least equal to the volume-weighted average of the share prices over the three...

Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia

2026-06-23T05:15:00Z

Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia

argenx to Host Autoimmune Myositis R&D Webinar

2026-06-23T05:00:00Z

June 23, 2026, 7:00 AM CET

Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses

2026-06-23T05:00:00Z

Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses

Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2026-06-23T00:49:59Z

SAN MATEO, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that...

COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment

2026-06-23T00:16:00Z

TORONTO, ONTARIO, June 22, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) announced the next steps in connection with changes to the Company’s...

The Health Institute Announces Heal Your Cells, a New Book by Dr. Josh Axe and Dr. Will Cole on Cellular Health and Healthy Aging

2026-06-22T23:00:00Z

Inspired by personal loss and years of clinical practice, the forthcoming release explores how cellular function may influence energy, wellness, and long-term health.

Transactions of Managers and Closely Associated Persons

2026-06-22T22:48:04Z

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 10,133,333...

Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

2026-06-22T21:40:00Z

MELBOURNE, Australia and INDIANAPOLIS, June 23, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces an educational webinar exploring the unmet needs in neurologic oncology...

Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

2026-06-22T21:30:00Z

TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Thursday,...

Pioneering screening test offers potential to find more aggressive prostate cancers

2026-06-22T21:00:00Z

Annals of Internal Medicine publishes study showing potential benefits of Stockholm3 in identifying patients with aggressive prostate cancer

20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month

2026-06-22T20:45:00Z

Inaugural Session to be Held Wednesday, July 1, 2026, at 12:00 p.m. ET

MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval

2026-06-22T20:43:38Z

ROCKVILLE, MD, June 22, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that...

Elevar Therapeutics Announces First Patients Dosed in Phase 2 Study of Lirafugratinib Among Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

2026-06-22T20:27:19Z

FORT LEE, N.J., June 22, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences...